PRIMAXIN IV is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Imipenem; Cilastatin Sodium.
Product ID | 0006-3516_25896be0-b49d-43cd-8f90-105327b2ecfe |
NDC | 0006-3516 |
Product Type | Human Prescription Drug |
Proprietary Name | PRIMAXIN IV |
Generic Name | Imipenem And Cilastatin Sodium |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1985-11-26 |
Marketing Category | NDA / NDA |
Application Number | NDA050587 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | IMIPENEM; CILASTATIN SODIUM |
Active Ingredient Strength | 500 mg/100mL; mg/100mL |
Pharm Classes | Carbapenems [CS],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1985-11-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050587 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1985-11-26 |
Ingredient | Strength |
---|---|
IMIPENEM | 500 mg/100mL |
SPL SET ID: | f41d8abd-7792-4918-1b93-bd83ea01955e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
63323-322 | Imipenem and Cilastatin | Imipenem and Cilastatin Sodium |
63323-349 | Imipenem and Cilastatin | Imipenem and Cilastatin Sodium |
0006-3516 | PRIMAXIN | imipenem and cilastatin sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PRIMAXIN 73446124 1297360 Live/Registered |
Merck & Co., Inc. 1983-09-30 |